Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Expands By 34.8%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 22,100 shares, a growth of 34.8% from the January 15th total of 16,400 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Basilea Pharmaceutica Stock Performance

Shares of BPMUF remained flat at $52.83 during midday trading on Friday. The company has a debt-to-equity ratio of 5.70, a quick ratio of 3.27 and a current ratio of 4.10. Basilea Pharmaceutica has a 12-month low of $38.60 and a 12-month high of $52.83. The company has a fifty day moving average of $52.83 and a 200 day moving average of $51.79.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.